{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Yao Y"],"funding":["Natural Science Foundation of Jiangxi Province","National Natural Science Foundation of China"],"pagination":["22"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11762907"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["23(1)"],"pubmed_abstract":["<h4>Purpose</h4>This study aimed to determine the optimal natural orifice specimen extraction (NOSE) method for robotic-assisted mid-rectal cancer resection in women.<h4>Methods</h4>This retrospective propensity score-matched (PSM) study was to analyze the clinical data prospectively collected from female rectal cancer patients who underwent either robotic-assisted transvaginal specimen extraction (RATV) or robotic-assisted transanal specimen extraction (RATA) at our center between June 2016 and December 2022. The main outcome measures were urinary, anal, and sexual function. Disease-free survival (DFS), and overall survival (OS) were also included .<h4>Results</h4>Anal function, assessed by the Wexner score, was better in the RATV group than in the RATA group (P = 0.034). Additionally, pr"],"journal":["World journal of surgical oncology"],"pubmed_title":["Efficacy comparison of optimal natural orifice specimen extraction for robotic middle rectal cancer resection in women: transanal or transvaginal orifice."],"pmcid":["PMC11762907"],"funding_grant_id":["20202BABL206082","82160561"],"pubmed_authors":["Ju H","Liu Y","Yao Y","Yang L","Li T","Liang Y","Lei X","Ding J","Yuan Y"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy comparison of optimal natural orifice specimen extraction for robotic middle rectal cancer resection in women: transanal or transvaginal orifice.","description":"<h4>Purpose</h4>This study aimed to determine the optimal natural orifice specimen extraction (NOSE) method for robotic-assisted mid-rectal cancer resection in women.<h4>Methods</h4>This retrospective propensity score-matched (PSM) study was to analyze the clinical data prospectively collected from female rectal cancer patients who underwent either robotic-assisted transvaginal specimen extraction (RATV) or robotic-assisted transanal specimen extraction (RATA) at our center between June 2016 and December 2022. The main outcome measures were urinary, anal, and sexual function. Disease-free survival (DFS), and overall survival (OS) were also included .<h4>Results</h4>Anal function, assessed by the Wexner score, was better in the RATV group than in the RATA group (P = 0.034). Additionally, pr","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-05T11:34:38.454Z","creation":"2025-04-05T11:34:38.454Z"},"accession":"S-EPMC11762907","cross_references":{"pubmed":["39856731"],"doi":["10.1186/s12957-024-03630-z"]}}